| Ripretinib studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT05957367Phase 1/Phase 2 · recruiting A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618377Phase 1 · recruiting Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04633122Phase 2 · completed A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03673501Phase 3 · active not recruiting A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734105Phase 3 · active not recruiting A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06619275completed Ripretinib (QINLOCK®) According to Current SmPC · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282980Phase 2 · completed A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST) · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530981Phase 1 · completed A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02571036Phase 1 · completed A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies · 13 trials list this drug (4 active) | — | — | Malignant Neoplasm,Malignant Mastocytosis,Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05697107unknown Ripretinib in Chinese Patients With Advanced GIST: a Real World Study · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03353753Phase 3 · completed Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080621Phase 1/Phase 2 · withdrawn Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST) · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04148092approved for marketing Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST · 13 trials list this drug (4 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |